Researchers analyzed both RNA sequencing data and corresponding clinical outcomes obtained from public databases to identify (i) NLR family CARD domain containing 3 (NLRC3) gene as a tumor suppressor in lung adenocarcinoma (LUAD) and (ii) its predictive value for the likelihood of patient responsiveness to immunotherapy.
[Scientific Reports]